Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial
在 II 期临床试验中，接受帕博利珠单抗治疗的罕见癌症患者报告的症状负担
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-022-16588-3
Mendoza, Tito R; Hong, David S; Peterson, Christine B; Stephen, Bettzy; Dumbrava, Ecaterina; Pant, Shubbam; Tsimberidou, Apostolia Maria; Yap, Timothy Anthony; Sheshadri, Ajay; Altan, Mehmet; George, Goldy; Castillo, Lilibeth; Rodriguez, Enedelia; Gong, Jing; Subbiah, Vivek; Janku, Filip; Fu, Siqing; Piha-Paul, Sarina A; Ahnert, Jordi Rodon; Karp, Daniel D; Cleeland, Charles; Meric-Bernstam, Funda; Naing, Aung
